B-cell acute lymphoblastic leukemia in an elderly man with plasma cell myeloma and long-term exposure to thalidomide and lenalidomide: a case report and literature review

BACKGROUND: The advent of the immunomodulatory imide drugs (IMiDs) lenalidomide and thalidomide for the treatment of patients with plasma cell myeloma (PCM), has contributed to more than a doubling of the overall survival of these individuals. As a result, PCM patients join survivors of other malign...

Descripción completa

Detalles Bibliográficos
Autores principales: Sinit, Ryan B., Hwang, Dick G., Vishnu, Prakash, Peterson, Jess F., Aboulafia, David M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6882354/
https://www.ncbi.nlm.nih.gov/pubmed/31775673
http://dx.doi.org/10.1186/s12885-019-6286-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6882354/
https://www.ncbi.nlm.nih.gov/pubmed/31775673
http://dx.doi.org/10.1186/s12885-019-6286-9

Ejemplares similares